|
Accueil > Actualité
Moderna: 2022 EPS down 29%
(CercleFinance.com) - Moderna has reported FY 2022 sales of $19.
3bn, up from $18.5bn in 2021, with business still driven by increased sales of the company's COVID-19 vaccines. The company also says that it increased its R&D spending by 65% to $3.3bn. As a result, net profit fell 31% to $8.4bn, while EPS was down preety much the same (-29%) at $20.12. Copyright (c) 2023 CercleFinance.com. All rights reserved. |
19/04/2024 16:35
TotalEnergiespartenariat avec OK Petroleum aux USA 19/04/2024 16:29 BAE Systemsmodernise une usine de munitions 19/04/2024 16:15 Netflixle titre trébuche après une publication contrastée 19/04/2024 16:09 Bayersigne un contrat de fourniture d'énergie renouvelables 19/04/2024 15:53 L'Oréalentouré après ses ventes trimestrielles 19/04/2024 15:45 Nissanrévision à la baisse des prévisions sur l'exercice Tous les articles sociétés |
